Home > Qtrly Results > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Quarterly Results Analysis [Jun2025]

EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Revenues ₹2,101 Cr ₹2,116 Cr ₹1,963 Cr ₹2,002 Cr ₹1,815 Cr ₹1,771 Cr ₹1,668 Cr ₹1,663 Cr
Expenses ₹1,684 Cr ₹1,714 Cr ₹1,608 Cr ₹1,621 Cr ₹1,478 Cr ₹1,461 Cr ₹1,361 Cr ₹1,334 Cr
Operating Income ₹417 Cr ₹402 Cr ₹355 Cr ₹381 Cr ₹337 Cr ₹311 Cr ₹307 Cr ₹329 Cr
Other Income ₹4 Cr ₹4 Cr ₹4 Cr ₹36 Cr ₹23 Cr ₹12 Cr ₹16 Cr ₹1 Cr
Interest ₹27 Cr ₹39 Cr ₹32 Cr ₹46 Cr ₹59 Cr ₹65 Cr ₹61 Cr ₹59 Cr
Depreciation ₹99 Cr ₹97 Cr ₹97 Cr ₹97 Cr ₹94 Cr ₹91 Cr ₹84 Cr ₹70 Cr
Profit Before Tax ₹291 Cr ₹261 Cr ₹230 Cr ₹273 Cr ₹207 Cr ₹167 Cr ₹171 Cr ₹198 Cr
Profit After Tax ₹215 Cr ₹197 Cr ₹156 Cr ₹202 Cr ₹153 Cr ₹121 Cr ₹120 Cr ₹146 Cr
EPS ₹10.92 ₹9.97 ₹8.11 ₹10.29 ₹7.95 ₹6.36 ₹6.27 ₹7.69
Industry Peers & Returns1W1M1Y
EMCURE PHARMACEUTICALS -2.5% 0.6% -8.5%
SUN PHARMACEUTICAL INDUSTRIES -0.3% 3.2% -13%
DIVIS LABORATORIES 7.2% 8.6% 6.8%
CIPLA 3% 0.7% -2.6%
TORRENT PHARMACEUTICALS -0.5% NA 0.6%
DR REDDYS LABORATORIES -1.1% -5.3% -6.3%
MANKIND PHARMA -1.4% -5.3% -12.8%
ZYDUS LIFESCIENCES -1.9% -5.7% -8.1%
LUPIN -0.9% -5.2% -12.9%

EMCURE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-0.74 %

Y-o-Y

15.72 %

Quarters Revenues % Change
Jun2025 ₹2,101 Cr
-0.74
Mar2025 ₹2,116 Cr
7.83
Dec2024 ₹1,963 Cr
-1.97
Sep2024 ₹2,002 Cr
10.29
Jun2024 ₹1,815 Cr
2.47
Mar2024 ₹1,771 Cr
6.22
Dec2023 ₹1,668 Cr
0.27
Sep2023 ₹1,663 Cr -

EMCURE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

3.57 %

Y-o-Y

23.79 %

Quarters Operating Profit % Change
Jun2025 ₹417 Cr
3.57
Mar2025 ₹402 Cr
13.48
Dec2024 ₹355 Cr
-6.90
Sep2024 ₹381 Cr
13.13
Jun2024 ₹337 Cr
8.37
Mar2024 ₹311 Cr
1.22
Dec2023 ₹307 Cr
-6.72
Sep2023 ₹329 Cr -
Operating Margins
Q-o-Q

4.37 %

Y-o-Y

6.95 %

Quarters Operating Margin% % Change
Jun2025 19.84%
4.37
Mar2025 19.01%
5.20
Dec2024 18.07%
-4.99
Sep2024 19.02%
2.53
Jun2024 18.55%
5.76
Mar2024 17.54%
-4.73
Dec2023 18.41%
-6.97
Sep2023 19.79% -

EMCURE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

8.90 %

Y-o-Y

40.76 %

Quarters Profit After Tax % Change
Jun2025 ₹215 Cr
8.90
Mar2025 ₹197 Cr
26.36
Dec2024 ₹156 Cr
-22.55
Sep2024 ₹202 Cr
32.09
Jun2024 ₹153 Cr
26.09
Mar2024 ₹121 Cr
1.05
Dec2023 ₹120 Cr
-17.88
Sep2023 ₹146 Cr -
PAT Margins
Q-o-Q

9.76 %

Y-o-Y

21.64 %

Quarters PAT Margin(%) % Change
Jun2025 10.23 %
9.76
Mar2025 9.32 %
17.23
Dec2024 7.95 %
-21.05
Sep2024 10.07 %
19.74
Jun2024 8.41 %
23.13
Mar2024 6.83 %
-4.87
Dec2023 7.18 %
-18.13
Sep2023 8.77 % -

EMCURE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

9.53 %

Y-o-Y

37.36 %

Quarters EPS % Change
Jun2025 ₹10.92
9.53
Mar2025 ₹9.97
22.93
Dec2024 ₹8.11
-21.19
Sep2024 ₹10.29
29.43
Jun2024 ₹7.95
25.00
Mar2024 ₹6.36
1.44
Dec2023 ₹6.27
-18.47
Sep2023 ₹7.69 -

You may also like the below Video Courses